Kairos Pharma Ltd (AMEX:KAPA) has seen 241.3 million shares traded in the last trading session. The company, currently valued at $19.71M, closed the last trade at $1.17 per share which meant it gained $0.48 on the day or 70.78% during that session. The KAPA stock price is -241.88% off its 52-week high price of $4.00 and 65.81% above the 52-week low of $0.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.54 million shares traded. The 3-month trading volume is 887.64K shares.
Kairos Pharma Ltd (AMEX:KAPA) trade information
Over the past 30 days, the shares of Kairos Pharma Ltd (AMEX:KAPA) have changed 105.26%. Short interest in the company has seen 0.19 million shares shorted with days to cover at 0.12.
Kairos Pharma Ltd (KAPA) estimates and forecasts
The company’s shares have gained 20.62% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.37% over the past 5 years. Earnings growth for 2025 is a modest 7.25% while over the next 5 years, the company’s earnings are expected to decrease by -24.45%.
KAPA Dividends
Kairos Pharma Ltd is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Kairos Pharma Ltd (AMEX:KAPA)’s Major holders
Insiders own 47.25% of the company shares, while shares held by institutions stand at 9.36% with a share float percentage of 17.75%. Investors are also buoyed by the number of investors in a company, with Kairos Pharma Ltd having a total of 8.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of May 31, 2025 , the former fund manager holds about 0.10% shares in the company for having 16.76 shares of worth $19605.0 while later fund manager owns 5.05 shares of worth $5904.0 as of May 31, 2025 , which makes it owner of about 0.03% of company’s outstanding stock.
